AWM
ABBV icon

Atticus Wealth Management’s AbbVie ABBV Stock Holding History

Atticus Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$801K Sell
3,183
-32
-1% -$6.88K 0.19% 77
2026
Q1 		$699K Sell
3,215
-394
-11% -$87.4K 0.19% 85
2025
Q4 		$825K Sell
3,609
-113
-3% -$25.7K 0.2% 73
2025
Q3 		$862K Buy
3,722
+24
+0.6% +$4.89K 0.22% 67
2025
Q2 		$686K Sell
3,698
-42
-1% -$7.81K 0.19% 69
2025
Q1 		$784K Sell
3,740
-37
-1% -$7.19K 0.26% 54
2024
Q4 		$671K Buy
3,777
+3
+0.1% +$552 0.21% 61
2024
Q3 		$745K Buy
3,774
+60
+2% +$11.2K 0.24% 52
2024
Q2 		$637K Sell
3,714
-274
-7% -$45.4K 0.21% 56
2024
Q1 		$726K Sell
3,988
-238
-6% -$41K 0.24% 52
2023
Q4 		$655K Sell
4,226
-1,011
-19% -$147K 0.23% 55
2023
Q3 		$781K Buy
5,237
+6
+0.1% +$881 0.3% 48
2023
Q2 		$705K Buy
5,231
+5
+0.1% +$733 0.26% 57
2023
Q1 		$833K Buy
5,226
+55
+1% +$8.41K 0.32% 48
2022
Q4 		$836K Sell
5,171
-52
-1% -$7.97K 0.34% 52
2022
Q3 		$800K Hold
5,223
– – 0.39% 40
2022
Q2 		$800K Buy
5,223
+560
+12% +$85.6K 0.33% 52
2022
Q1 		$756K Buy
4,663
+1,612
+53% +$234K 0.28% 59
2021
Q4 		$413K Sell
3,051
-617
-17% -$72.9K 0.16% 86
2021
Q3 		$396K Buy
3,668
+8
+0.2% +$914 0.17% 69
2021
Q2 		$412K Buy
3,660
+284
+8% +$32K 0.18% 75
2021
Q1 		$365K Buy
3,376
+2
+0.1% +$214 0.17% 78
2020
Q4 		$362K Buy
3,374
+405
+14% +$38.9K 0.18% 70
2020
Q3 		$260K Buy
2,969
+314
+12% +$29.6K 0.16% 75
2020
Q2 		$261K Sell
2,655
-524
-16% -$46.1K 0.17% 76
2020
Q1 		$242K Buy
3,179
+9
+0.3% +$767 0.2% 69
2019
Q4 		$281K Buy
+3,170
New +$263K 0.18% 70

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Atticus Wealth Management's ABBV Position: Q2 2026 in Review

Atticus Wealth Management reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $6.88K and leaving 3,183 shares worth $801K. The position accounts for 0.19% of the portfolio, ranked #77.

Atticus Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $862K in Q3 2025. 1,762 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atticus Wealth Management held 3,183 shares of AbbVie worth $801K as of Q2 2026.
  • Atticus Wealth Management sold 32 AbbVie shares in Q2 2026, an estimated $6.88K.
  • AbbVie made up 0.19% of Atticus Wealth Management's portfolio in Q2 2026, its #77 holding.
  • Atticus Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Atticus Wealth Management's AbbVie position peaked at $862K in Q3 2025.
  • 1,762 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atticus Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.